This healthcare evaluation aims to evaluate whether adding perineoplasty is - in comparison to performing vaginal
prolapse surgery without adding perineoplasty - superior with respect to efficacy and cost-effectiveness and non-inferior with respect to morbidity, in patients undergoing vaginal surgical correction of pelvic organ prolapse at 24 months after surgery.